If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVerici Dx Regulatory News (VRCI)

Share Price Information for Verici Dx (VRCI)

Share Price is delayed by 15 minutes
Get Live Data
0.375    0.00 (0.00%)
Bid:
0.35
Ask:
0.40
Spread: 0.05 (14.286%)
Market Cap: £11.20m
VRCI Live PriceLast checked at - London Stock Exchange

Intraday Verici Dx Share Chart

Net Asset Value(s)

26 Jan 2022 16:28

RNS Number : 7538Z
China Post Global
26 January 2022
 

 

FUND:

MARKET ACCESS NYSE ARCA GOLD BUGS INDEX UCITS ETF

DEALING DATE:

25/01/2022

NAV PER SHARE:

 

 

EUR 92.9912

GBP 77.6544

NUMBER OF SHARES IN ISSUE:

813,533

CODE:

GOLB

ISIN:

LU0259322260

 

 

FUND:

MARKET ACCESS ROGERS INTERNATIONAL COMMODITY INDEX UCITS ETF

DEALING DATE:

25/01/2022

NAV PER SHARE:

 

 

EUR 24.8409

GBP 20.7440

NUMBER OF SHARES IN ISSUE:

3,125,122

CODE:

RICI

ISIN:

LU0249326488

 

 

FUND:

MARKET ACCESS STOXX CHINA A MINIMUM VARIANCE INDEX UCITS ETF

DEALING DATE:

26/01/2022

NAV PER SHARE:

 

 

EUR 115.9559

GBP 96.8316

NUMBER OF SHARES IN ISSUE:

238,711

CODE:

M9SV

ISIN:

LU1750178011

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQQLFLLFLLBBD
Date   Source Headline
11th Mar 20229:30 amRNSClose of Subscription and Fundraise Update
4th Mar 20224:13 pmRNSResult of Fundraise
4th Mar 202212:20 pmRNSClose of Accelerated Bookbuild
4th Mar 20227:10 amRNSProposed Fundraise
15th Feb 20227:00 amRNSSuccessful completion of analytical validation
26th Jan 20224:28 pmRNSNet Asset Value(s)
14th Jan 20227:00 amRNSInvestor Presentation
12th Jan 20222:00 pmRNSProgress and strategy update
6th Jan 20227:00 amRNSClarava™ and Tuteva™ complete testing requirements
5th Jan 20227:00 amRNSCollaboration with Illumina
4th Jan 20227:00 amRNSGrant of two CPT Codes by AMA
17th Dec 20211:19 pmRNSHolding(s) in Company
8th Nov 20217:00 amRNSLaunch of Barbara T. Murphy Endowed Lectureship
1st Nov 20217:00 amRNSLaunch of Career Development Research Grant
13th Sep 20217:01 amRNSLorenzo Gallon, MD, Appointed as Chair of S.A.B
13th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSPatient enrolment completed
19th Aug 20217:00 amRNSAppointment of Non-executive Director
27th Jul 20217:00 amRNSAcceptance to CLIA Program
20th Jul 20217:00 amRNSFirst European Clinical Trial Site Initiated
1st Jul 20214:56 pmRNSDirectorate Change
24th Jun 20217:00 amRNSNon-executive Director receives award
26th May 20214:41 pmRNSSecond Price Monitoring Extn
26th May 20214:35 pmRNSPrice Monitoring Extension
19th May 20213:14 pmRNSResult of AGM
5th May 20217:00 amRNSNotice of Change of AGM Venue
29th Apr 20217:00 amRNSLease signed for laboratory
14th Apr 20217:01 amRNSMTA secured to assess CTOT-19 samples
14th Apr 20217:00 amRNSFinal Results
13th Apr 20212:06 pmRNSSecond Price Monitoring Extn
13th Apr 20212:01 pmRNSPrice Monitoring Extension
13th Apr 202111:05 amRNSSecond Price Monitoring Extn
13th Apr 202111:00 amRNSPrice Monitoring Extension
17th Mar 20217:00 amRNSNotice of Results
2nd Mar 20217:00 amRNSFirst clinical trial sites initiated in US
9th Feb 20217:00 amRNSCapital Markets Day for Kidney Health
8th Feb 20217:00 amRNSAccelerated CLIA approval strategy
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Jan 202111:05 amRNSSecond Price Monitoring Extn
18th Jan 202111:01 amRNSPrice Monitoring Extension
15th Jan 20214:40 pmRNSSecond Price Monitoring Extn
15th Jan 20214:35 pmRNSPrice Monitoring Extension
11th Jan 20217:00 amRNSAdditional patent licence with Mount Sinai
23rd Dec 20207:00 amRNSAppointment of Senior Director
12th Nov 20204:34 pmRNSHolding(s) in Company
12th Nov 20204:34 pmRNSHolding(s) in Company
5th Nov 20205:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.